Former Merck executive Michael Nally will become a partner at life sciences platform firm Flagship Pioneering and serve as chief executive of its startup company Generate Biomedicines. Nally spent 18 years at Merck and had been mentioned as a candidate for the  CEO role, but left the company after Robert Davis was chosen to succeed Ken Frazier.